-
Document de presse | 2024.11.12
A*STAR IDL and Institut Pasteur unite their expertise to boost infectious diseases research across the asia-pacific region
Singapore’s Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) and France’s Institut Pasteur have signed a Memorandum of Understanding (MoU) to address the urgent health threats posed by the rise of tropical infectious diseases (ID) in the Asia-Pacific region. Together, this partnership would enable both parties to co-develop innovative technologies with...
-
Document de presse | 2025.01.31
IRD, DNDi, Institut Pasteur de Guinée and the Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Guinea celebrates today the elimination of sleeping sickness (also known as human African trypanosomiasis or HAT) as a public health problem.Despite health crises such as the 2013-2015 Ebola epidemic and the SARS-Cov2 pandemic, combined medical and vector control strategies have enabled Guinea to reach the threshold of eliminating sleeping sickness as a public health problem (less than one case...
-
Document de presse | 2025.01.16
Institut Pasteur decides to leave X
The Institut Pasteur, a research organization which for more than 130 years has been committed to tackling infectious diseases, sharing knowledge and defending science, has decided to leave X because of several serious abuses observed on the platform since its takeover by Elon Musk. We are suspending our day-to-day activities on the platform immediately and will encourage our subscribers to...
-
Document de presse | 2024.12.06
From Yemen to Mayotte, the spread of a highly drug-resistant cholera strain
Scientists from the National Reference Center for Vibrios and Cholera at the Institut Pasteur, in collaboration with the Centre hospitalier de Mayotte, have revealed the spread of a highly drug-resistant cholera strain. The study was published on December 12, 2024 in the New England Journal of Medicine. Cholera is an infectious diarrheal disease caused by certain bacteria of the species Vibrio...
-
Document de presse | 2024.11.21
Phages, towards a targeted alternative to antibiotics
With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists – although it remains complex in...
-
Vidéo | 2025.02.04
What is bronchiolitis?
Bronchiolitis, a respiratory infection affecting infants, is caused in 60-80% of cases by the respiratory syncytial virus (RSV). It begins as a cold with moderate fever, but can lead to coughing, difficulty breathing, wheezing and eating disorders. Marie-Anne Rameix-Welti, respiratory virus expert at the Institut Pasteur, shares essential advice on protecting infants from bronchiolitis.Prevention...
-
News | 2025.02.10
Women scientists: inspiring faces of research at the Institut Pasteur
The International Day of Women and Girls in Science 2025 is an opportunity to shine the spotlight on committed and talented women researchers. In addition to their scientific work, these Institut Pasteur scientists, also called Pasteurians, are creative person involved in scientific outreach who work to make science accessible to all (all videos below in French).
-
Page avancée | 2025.01.21
Pasteur 2030
Strengthening our position as a global reference in research on infection and populations' health.
-
Article | 2019.09.17
A favorable technological environment
Technological progress is opening up innovative research fields that will pave the way for new treatment possibilities tailored to the environment and needs of local populations, as part of a broader approach to healthcare.Providing the Institut Pasteur research teams with access to cutting-edge resources and expertise in the fields of technology and animal research to advance their discoveries...
-
Article | 2019.06.18
Cancer Initiative at the Institut Pasteur
The Cancer Initiative is a concerted action by Institut Pasteur laboratories working on cancer. It aims to build and support research on cancer by fostering a multidisciplinary and translational approach that combines cell, molecular and structural biology, genetics, developmental and stem cell biology, microbiology, virology, infection biology, immunology, chemistry and computational biology.
